Elsevier Unveils Comprehensive AI Platform for Researchers

Elsevier Unveils Comprehensive AI Platform for Researchers

India Pharma Outlook Team | Thursday, 18 September 2025

 Elsevier AI solution, ScienceDirect AI, Scopus AI

Elsevier has revealed a comprehensive AI platform for researchers to reshape how academic and corporate sectors conduct work. The goal of this advanced platform is to empower scientists to transition quickly from insights to real-world implementation all while safeguarding research integrity, transparency, and trust.

Following the success of ScienceDirect AI and Scopus AI, Elsevier's all-in-one comprehensive AI solution will act like a seamless assistant. It will help researchers to identify areas for inquiry, gaps in knowledge, synthesizing literature, and connecting researchers with collaborators to accelerate productivity.

Also Read: Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections

Unlike generative AI tools that work with limited datasets and lack transparency, this AI solution is built around one of the highest quality content aggregations, consisting of subscription and open access content from publishers that offer deeper and broader coverage and understanding of the emerging literature in your field.

The use of AI is backed by Elsevier's Responsible AI Principles which ensure that there is transparency, human intervention, and real-world impact. Each use of the AI will augment a researcher’s expertise and be transparent in terms of how output conclusions reached.

Judy Verses, president, Academic and Government Markets, Elsevier said: “Working together with the research community, our goal is to help researchers seamlessly carry out multiple…we aim to create a next-level experience for impact makers who are advancing human progress.”   Professor Minoru Terano, president, Japan Advanced Institute of Science and Technology (JAIST), said: “Our researchers are engaged in the latest research to address the world's big challenges…ensuring progress that drives academic excellence and societal impact.”

With millions of interconnected records from Scopus and trusted ScienceDirect content, Elsevier’s AI solution promises to redefine research workflows, helping global researchers tackle complex challenges more efficiently and confidently.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.